Scarica l'app Stockscreener
16.81
3.77%
0.61
Dopo l'orario di chiusura:
17.20
0.39
+2.32%
Precedente Chiudi:
$16.20
Aprire:
$16.07
Volume 24 ore:
298.44K
Relative Volume:
2.94
Capitalizzazione di mercato:
$215.94M
Reddito:
$16.96M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-8.0162
EPS:
-2.097
Flusso di cassa netto:
$-20.66M
1 W Prestazione:
+7.00%
1M Prestazione:
-3.45%
6M Prestazione:
-1.52%
1 anno Prestazione:
+3.96%
Intervallo 1D:
$15.51
$17.53
Intervallo di 1 settimana:
$14.90
$17.53
Portata 52W:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
16.81 | 215.94M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million - sahmcapital.com
MediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
MediWound (MDWD) Gains as Vericel Secures $197M Contract for Nex - GuruFocus
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid - TipRanks
BARDA’s up-to-$197M NexoBrid contract highlighted by MediWound (MDWD) - Stock Titan
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan
Aug Highlights: Is MediWound Ltd forming a bullish divergence2026 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus - The Globe and Mail
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
MediWound (NASDAQ: MDWD) plans 2026 AGM, director slate and CEO bonus - Stock Titan
Fed Meeting: Should value investors consider MediWound LtdSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
MediWound (MDWD) director details options, RSU and share holdings - stocktitan.net
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 earnings call transcript - msn.com
Gap Down: Can MediWound Ltd keep up with sector leaders2026 Sector Review & Smart Swing Trading Alerts - baoquankhu1.vn
Pullback Watch: Does MediWound Ltd meet Warren Buffetts criteriaEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in MDWD Response - news.stocktradersdaily.com
Aug Drivers: Will MediWound Ltd outperform the market in YEARGap Down & Verified Short-Term Plans - baoquankhu1.vn
MediWound (MDWD) director Rubinstein reports options and share holdings - Stock Titan
[Form 3] MediWound Ltd. Initial Stateme... - Stock Titan
MediWound (MDWD) CMO details options and RSU awards in Form 3 filing - Stock Titan
MediWound Ltd. (MDWD) director discloses shares, RSUs and options stake - Stock Titan
MediWound (MDWD) VP reports stock options and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) EVP Meyer Yaron files Form 3 on equity holdings - Stock Titan
MediWound (MDWD) details director Stephen Wills’ initial share and option holdings - Stock Titan
MediWound (MDWD) COO Shmuel details option and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) CEO details warrants, RSUs and options in Form 3 - Stock Titan
MediWound (MDWD) director Nachum Shamir details shares, RSUs and options - Stock Titan
MediWound (MDWD) Stock Price, News & Analysis - MarketBeat
Medical Maggots Market Hits New High | Major Giants BioMonde, Maggot Therapy, MediWound - openPR.com
Menora Mivtachim Holdings LTD. Purchases 61,039 Shares of MediWound Ltd. $MDWD - MarketBeat
Rosalind Advisors Inc. Buys 341,993 Shares of MediWound Ltd. $MDWD - MarketBeat
Performance Recap: Is MediWound Ltd forming a bullish divergenceDip Buying & AI Optimized Trading Strategy Guides - baoquankhu1.vn
FY2030 Earnings Estimate for MediWound Issued By Maxim Group - Defense World
Institution Moves: Does MediWound Ltd meet Warren Buffetts criteria2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
FY2030 Earnings Forecast for MediWound Issued By Maxim Group - MarketBeat
MediWound Is the Biotech Governments Have Been Stockpiling for E - GuruFocus
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD) - TipRanks
MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs - MSN
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MDWD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Behavioral Patterns of MDWD and Institutional Flows - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 Earnings Call Transcript - Insider Monkey
MediWound: Q4 Earnings Snapshot - theheraldreview.com
Alliance Global Partners Keeps Their Buy Rating on Mediwound (MDWD) - The Globe and Mail
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
MediWound Q4 Earnings Call Highlights - MarketBeat
MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative - simplywall.st
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):